Why this resource exists.
Vesper Rationale exists to make difficult questions easier to approach with care. It offers clear, evidence-first information on microdosing ibogaine, including uncertainty, legal context, and serious safety concerns.
The point is not to direct anyone toward a decision. It is to make room for a more measured starting point: plain language, visible limits, and an honest account of what is known and what is not. The main reference is arranged for adults who want a careful route into the subject without promotional framing.
We recognize that medical claims deserve scrutiny. The FDA’s drug development process illustrates why evidence, safety assessment, and regulatory review matter before confident conclusions are drawn.